Yiling Lu

128.2k citations

209 papers · 15.6k indexed · 3 hit papers · h-index 64

Cancer Research top 0.5%
Molecular Biology top 0.2%
- PI3K/AKT/mTOR signaling in cancer 40
- Advanced Biosensing Techniques and Applications 25
- Protein Kinase Regulation and GTPase Signaling 13
- Gene expression and cancer classification 13
Oncology top 0.5%
Cell Biology top 0.5%
Reproductive Medicine top 1%
- Ovarian cancer diagnosis and treatment 13
Spectroscopy
- Advanced Proteomics Techniques and Applications 19
Radiology, Nuclear Medicine and Imaging
- Monoclonal and Polyclonal Antibodies Research 16
Pathology and Forensic Medicine
- Cancer Mechanisms and Therapy 13

Co-authors: Gordon B. Mills Bryan T. Hennessy Prahlad T. Ram Debra L. Smith Xianjun Fang Robert C. Bast Shuangxing Yu James R. Woodgett
Cited by: Cancer Research Molecular Biology Oncology
Journals: Cancer Research (26 papers)Journal of Biological Chemistry (9 papers)Oncogene (9 papers)
Partner nations: United States China United Kingdom

In The Last Decade

Yiling Lu

203 papers receiving 15.3k citations

Hit Papers

align trajectories log scale

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

2005 Nature Reviews Drug Discovery
2000 Proceedings of the National Academy of Sciences
1999 Nature Genetics

Peers

Countries citing papers authored by Yiling Lu

Since Specialization

Citations

This map shows the geographic impact of Yiling Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yiling Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yiling Lu more than expected).

Fields of papers citing papers by Yiling Lu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yiling Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yiling Lu. The network helps show where Yiling Lu may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Yiling Lu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Yiling Lu Line = papers co-authored together Yiling Lu links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Latest Advancements of Natural Products in Combating Ovarian Cancer Journal of Cancer ·Yiling Lu,Raghad Jarallah,Yuling Chen,Baharuddin Baharuddin,Gonc Madeira,Ye Xu,Yuan Zhou,Fangfang Tao	2025	0
2	A protein expression atlas on tissue samples and cell lines from cancer patients provides insights into tumor heterogeneity and dependencies Nature Cancer ·Jun Li,Wei Liu,Kamalika Mojumdar,Hong Kim,Denis Žernov,Zhenlin Ju,Shwetha V. Kumar,Patrick Kwok‐Shing Ng,Han Chen,Michael A. Davies,Yiling Lu,Rehan Akbani,Gordon B. Mills,Han Liang	2024	6
3	Peritoneal Spread of Ovarian Cancer Harbors Therapeutic Vulnerabilities Regulated by FOXM1 and EGFR/ERBB2 Signaling Cancer Research ·Deepak Parashar,E Rutty,Anjali Geethadevi,Jasmine George,Ajay Nair,Shirng‐Wern Tsaih,Fengge Wen,Gopa Kumar Gopinadhan Nair,Yiling Lu,Ramani Ramchandran,Denise Uyar,Janet S. Rader,Prahlad T. Ram,Gordon B. Mills,Sunila Pradeep,Pradeep Chaluvally–Raghavan	2020	29
4	YAP/TAZ-Mediated Upregulation of GAB2 Leads to Increased Sensitivity to Growth Factor–Induced Activation of the PI3K Pathway Cancer Research ·Chao Wang,Chao Gu,Kang Jin Jeong,Dong Zhang,Wei Guo,Yiling Lu,Zhenlin Ju,Nattapon Panupinthu,Ji Yeon Yang,Mihai Gagea,Patrick Kwok Shing Ng,Fan Zhang,Gordon B. Mills	2017	43
5	Explore, Visualize, and Analyze Functional Cancer Proteomic Data Using the Cancer Proteome Atlas Cancer Research ·Jun Li,Rehan Akbani,Wei Zhao,Yiling Lu,John N. Weinstein,Gordon B. Mills,Han Liang	2017	83
6	Oncogenic RAS Regulates Long Noncoding RNA Orilnc1 in Human Cancer Cancer Research ·Dongmei Zhang,Gao Zhang,Zhongyi Hu,Lawrence W. Wu,Yi Feng,R Oyen,Youyou Zhang,Lu Yang,Tian Tian,Weiting Xu,Zhi Wei,Yiling Lu,Keith T. Flaherty,Xiaomin Zhong,Gordon B. Mills,Phyllis A. Gimotty,Xiaowei Xu,Meenhard Herlyn,Lin Zhang	2017	29
7	HSP70 Inhibition Limits FAK-Dependent Invasion and Enhances the Response to Melanoma Treatment with BRAF Inhibitors Cancer Research ·Anna Budina-Kolomets,Marie R. Webster,Julia I-Ju Leu,Matthew Jennis,Clemens Krepler,Greg L. Miller,Andrew V. Kossenkov,Wei Xu,Giorgos C. Karakousis,Lynn M. Schuchter,Ravi K. Amaravadi,Hong Wu,Xiangfan Yin,Qin Liu,Yiling Lu,Gordon B. Mills,Xiaowei Xu,Donna L. George,Ashani T. Weeraratna,Maureen E. Murphy	2016	34
8	Integrative Protein-Based Prognostic Model for Early-Stage Endometrioid Endometrial Cancer Clinical Cancer Research ·Jiyeon Yang,Henrica M.J. Werner,Jie Li,Shannon N. Westin,Yiling Lu,Mari K. Halle,Jone Trovik,Helga B. Salvesen,Gordon B. Mills,Han Liang	2015	22
9	MAPK Activation Predicts Poor Outcome and the MEK Inhibitor, Selumetinib, Reverses Antiestrogen Resistance in ER-Positive High-Grade Serous Ovarian Cancer Clinical Cancer Research ·陽石垣,Philip C. Miller,Dorraya El‐Ashry,Jun Sun,Alexandra H. Besser,Tan A. Ince,Mengnan Gu,Zhi Wei,Gao Zhang,Patricia Brafford,Wei Gao,Yiling Lu,Gordon B. Mills,Joyce M. Slingerland,Fiona Simpkins	2015	46
10	Reverse-Phase Protein Array Profiling of Oropharyngeal Cancer and Significance of PIK3CA Mutations in HPV-Associated Head and Neck Cancer Clinical Cancer Research ·Andrew Sewell,Brandee Brown,Asel Biktasova,Gordon B. Mills,Yiling Lu,Darren R. Tyson,Natalia Issaeva,Wendell G. Yarbrough	2014	71
11	α-Tubulin Acetylation Elevated in Metastatic and Basal-like Breast Cancer Cells Promotes Microtentacle Formation, Adhesion, and Invasive Migration Cancer Research ·Amanda E. Boggs,Michele Vítolo,Rebecca A. Whipple,Monica S. Charpentier,Olga Goloubeva,Olga B. Ioffe,Kimberly C. Tuttle,C.D. Fonseca,Yiling Lu,Gordon B. Mills,Stuart S. Martin	2014	152
12	Network Analysis of the Focal Adhesion to Invadopodia Transition Identifies a PI3K-PKCα Invasive Signaling Axis Science Signaling ·Daisuke Hoshino,Jérôme Jourquin,Robert Skoczowsky,Tyne W. Miller‐Fleming,Giglio Rosaria Vincenza,Kaitlin Costello,Darren R. Tyson,Brandee Brown,Yiling Lu,K. Nagendra Prasad,Bing Zhang,Gordon B. Mills,Wendell G. Yarbrough,Vito Quaranta,Motoharu Seiki,Alissa M. Weaver	2012	70
13	Src Inhibition with Saracatinib Reverses Fulvestrant Resistance in ER-Positive Ovarian Cancer Models In Vitro and In Vivo Clinical Cancer Research ·Fiona Simpkins,Pahrezi Azhar,Jun Sun,Gustavo Di Giorgi Ramos,Candace A. Gilbert,سومية شكري محمد محمود,Ali Pedram,Ellis R. Levin,Isildinha M. Reis,Brian Rabinovich,Diana J. Azzam,Xiang‐Xi Xu,Tan A. Ince,Ji-Yeon Yang,Roel G.W. Verhaak,Yiling Lu,Gordon B. Mills,Joyce M. Slingerland	2012	54
14	Dual Inhibition of Tumor Energy Pathway by 2-Deoxyglucose and Metformin Is Effective against a Broad Spectrum of Preclinical Cancer Models Molecular Cancer Therapeutics ·Jae‐Ho Cheong,Eun Sung Park,Jiyong Liang,Jennifer B. Dennison,Dimitra Tsavachidou,Joonsuk Bae,Kwai Wa Cheng,Hassan Hall,Dong Zhang,Yiling Lu,Murali K. Ravoori,Vikas Kundra,Jaffer A. Ajani,Ju‐Seog Lee,Waun Ki Hong,Gordon B. Mills	2011	205
15	High Frequency of PIK3R1 and PIK3R2 Mutations in Endometrial Cancer Elucidates a Novel Mechanism for Regulation of PTEN Protein Stability Cancer Discovery ·Lydia W.T. Cheung,Bryan T. Hennessy,Jie Li,Shuangxing Yu,Andrea P. Myers,Bojana Djordjevic,Yiling Lu,Katherine Stemke‐Hale,Mary D. Dyer,Fan Zhang,Zhenlin Ju,Lewis C. Cantley,Steven E. Scherer,Han Liang,Karen H. Lu,Russell R. Broaddus,Gordon B. Mills	2011	352
16	Functional Proteomic Analysis of Advanced Serous Ovarian Cancer Using Reverse Phase Protein Array: TGF-β Pathway Signaling Indicates Response to Primary Chemotherapy Clinical Cancer Research ·Mark Carey,Roshan Agarwal,C. Blake Gilks,Kenneth D. Swenerton,Steve E. Kalloger,Лайло Кучкаровна Мансурова,Zhenlin Ju,Yiling Lu,Fan Zhang,Kevin R. Coombes,Dianne Miller,David Huntsman,Gordon B. Mills,Bryan T. Hennessy	2010	45
17	Integrative Analysis of Proteomic Signatures, Mutations, and Drug Responsiveness in the NCI 60 Cancer Cell Line Set Molecular Cancer Therapeutics ·Eun Sung Park,Rosalia Rabinovsky,Mark Carey,Bryan T. Hennessy,Roshan Agarwal,Wenbin Liu,Zhenlin Ju,Wanleng Deng,Yiling Lu,Hyun Goo Woo,Sang-Bae Kim,Jae‐Ho Cheong,Levi A. Garraway,John N. Weinstein,Gordon B. Mills,Ju‐Seog Lee,Michael A. Davies	2010	71
18	Identification of Optimal Drug Combinations Targeting Cellular Networks: Integrating Phospho-Proteomics and Computational Network Analysis Cancer Research ·Sergio Iadevaia,Yiling Lu,Fabiana C. Morales,Gordon B. Mills,Prahlad T. Ram	2010	164
19	A Vascular Targeted Pan Phosphoinositide 3-Kinase Inhibitor Prodrug, SF1126, with Antitumor and Antiangiogenic Activity Cancer Research ·Joseph R. Garlich,Pradip De,Nandini Dey,Jing Su,Xiaodong Peng,Lafon Jl,ISABEL AMARAL DE SOUZA,Yiling Lu,Gordon B. Mills,Vikas Kundra,常生林,Qiong Peng,Donald L. Durden	2008	230
20	Pharmacodynamic Markers of Perifosine Efficacy Clinical Cancer Research ·Bryan T. Hennessy,Yiling Lu,Enrique Poradosu,Álvaro Barrios–Núñez,Shuangxing Yu,Hassan Hall,Mark Carey,Murali K. Ravoori,Ana M. González-Angulo,Robert Birch,I. Craig Henderson,Vikas Kundra,Gordon B. Mills	2007	94

About Yiling Lu

Yiling Lu is a scholar working on Molecular Biology, Cancer Research and Reproductive Medicine, having authored 209 papers that have together received 15.6k indexed citations. Recurring topics across this work include PI3K/AKT/mTOR signaling in cancer (40 papers), Advanced Biosensing Techniques and Applications (25 papers), Advanced Proteomics Techniques and Applications (19 papers), Monoclonal and Polyclonal Antibodies Research (16 papers), Ovarian cancer diagnosis and treatment (13 papers), Protein Kinase Regulation and GTPase Signaling (13 papers), Gene expression and cancer classification (13 papers) and Cancer Mechanisms and Therapy (13 papers). The work is most often cited by research in Cancer Research (2.9k citations), Molecular Biology (11.6k citations) and Oncology (3.5k citations). Yiling Lu has collaborated with scholars based in United States, China and United Kingdom. Frequent co-authors include Gordon B. Mills, Bryan T. Hennessy, Prahlad T. Ram, Debra L. Smith, Xianjun Fang, Robert C. Bast, Shuangxing Yu, James R. Woodgett, Ruth LaPushin and Joe W. Gray. Their work appears in journals such as Cancer Research, Journal of Biological Chemistry, Oncogene, Cancer Cell and Clinical Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact